News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Solvay SA’s Operating Results (EUR 925 million) 5% Above the Excellent Results from the First 9 months of 2006 (+8% in the 3rd quarter)
October 26, 2007
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
BRUSSELS, BELGIUM--(Marketwire - October 26, 2007) - Embargo: Brussels, October 26, 2007 at 7:30 AM Solvay's operating results (EUR 925 million) 5% above the excellent results from the first 9 months of 2006 (+8% in the 3rd quarter)
Twitter
LinkedIn
Facebook
Email
Print
Earnings
Europe
MORE ON THIS TOPIC
Funding
Degron adds $40M to series A, supporting immunology plans for molecular glue platform
May 14, 2026
·
2 min read
·
Tristan Manalac
Layoffs
Takeda’s ‘transformation program’ leaves 4,500 jobless
May 14, 2026
·
2 min read
·
Tristan Manalac
Earnings
Goodbye Galapagos: chameleon company exits the island, rebrands as Lakefront
May 13, 2026
·
2 min read
·
Heather McKenzie
FDA
Makary’s out at FDA, Sanofi’s priority voucher issues, top exec pay
May 13, 2026
·
1 min read
·
Heather McKenzie